Dogecoin Frenzy Overloads Robinhood Crypto Order System
Bloomberg 2 hrs ago Joanna Ossinger and Vildana Hajric
(Bloomberg) The frenzy around digital tokens is taking its zaniest turn yet in the price of a token created as a joke, buckling the crypto trading system at Robinhood Markets.
Popular Searches
Dogecoin, boosted by the likes of Elon Musk and Mark Cuban, rallied more than 110% Friday, according to CoinMarketCap.com, reaching a market value of more than $45 billion. It’s now up 18,000% from a year ago, when it traded for $0.002 and was worth about $250 million.
Demand was so brisk for the token that investors trying to trade it on Robinhood crashed the site, the online exchange said in a blog post Friday. Some $68 billion worth of Dogecoin changed hands in the prior 24 hours as of 4:45 p.m. in New York, the most since June, CoinMarketCap.com data showed.
疯狂！这一加密货币单日暴拉200% 一年狂飙18000% 泡沫恐将破裂？
sina.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.cn Daily Mail and Mail on Sunday newspapers.
U S stock markets finished mixed, Nasdaq gains more than 1%
azerbaijannews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from azerbaijannews.net Daily Mail and Mail on Sunday newspapers.
Damian J. Troise and Alex Veiga
A choppy day of trading on Wall Street ended with indexes mixed Tuesday as a drop in bond yields hurt bank stocks but helped big technology companies.
The S&P 500 rose 0.3% after briefly slipping into the red in the early going. The modest gain nudged the benchmark index to an all-time high. Technology stocks and companies that rely on consumer spending helped lift the broad market index. The gains were tempered by a pullback in banks, industrial companies and other stocks.
Johnson & Johnson fell 1.3% after U.S. regulators recommended a pause in using its single-dose COVID-19 vaccine to investigate reports of possibly dangerous blood clots. Moderna, which also makes a COVID-19 vaccine, climbed 7.4%.